ELEV
Price:
$0.625
Market Cap:
$36.94M
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.[Read more]
Industry
Biotechnology
IPO Date
2021-06-25
Stock Exchange
NASDAQ
Ticker
ELEV
According to Elevation Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 41.10. This represents a change of 35.28% compared to the average of 30.38 of the last 4 quarters.
The mean historical Current Ratio of Elevation Oncology, Inc. over the last ten years is 11.85. The current 41.10 Current Ratio has changed 34.58% with respect to the historical average. Over the past ten years (40 quarters), ELEV's Current Ratio was at its highest in in the March 2024 quarter at 46.22. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
11.85
Median
11.91
Minimum
3.21
Maximum
21.22
Discovering the peaks and valleys of Elevation Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 271.38%
Maximum Annual Current Ratio = 21.22
Minimum Annual Increase = -65.15%
Minimum Annual Current Ratio = 3.21
Year | Current Ratio | Change |
---|---|---|
2023 | 21.22 | 258.17% |
2022 | 5.93 | -65.15% |
2021 | 17.00 | 42.79% |
2020 | 11.91 | 271.38% |
The current Current Ratio of Elevation Oncology, Inc. (ELEV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.72
5-year avg
11.85
10-year avg
11.85
Elevation Oncology, Inc.’s Current Ratio is less than CohBar, Inc. (0), greater than Ocean Biomedical, Inc. (4.16), greater than AVROBIO, Inc. (0.03), greater than Zura Bio Limited (26.17), greater than Enveric Biosciences, Inc. (12.57), greater than Hepion Pharmaceuticals, Inc. (7.37), greater than null (5.62),
Company | Current Ratio | Market cap |
---|---|---|
0 | $1.25M | |
4.16 | $33.96M | |
0.03 | $5.24M | |
26.17 | $230.86M | |
12.57 | $4.53M | |
7.37 | $4.20M | |
5.62 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elevation Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Elevation Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Elevation Oncology, Inc.'s Current Ratio?
How is the Current Ratio calculated for Elevation Oncology, Inc. (ELEV)?
What is the highest Current Ratio for Elevation Oncology, Inc. (ELEV)?
What is the 3-year average Current Ratio for Elevation Oncology, Inc. (ELEV)?
What is the 5-year average Current Ratio for Elevation Oncology, Inc. (ELEV)?
How does the current Current Ratio for Elevation Oncology, Inc. (ELEV) compare to its historical average?